Patents by Inventor Robert Bresalier

Robert Bresalier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210148912
    Abstract: Methods for detecting colorectal cancer or precancerous conditions such as adenomatous polyps in a subject by detection of a galactose-containing 40-kDa molecule in a serum sample from the subject are provided. Methods for quantifying the amount of a galactose-containing molecule in a serum sample are also provided. The methods can further comprise assaying the sample for the quantity of at least one additional marker to confirm the detection or diagnosis of colorectal cancer using one or more additional quantitative immune-detection assays; the additional marker can be at least one of galectin-3, a peptide derived from galectin-3, carcinoembryonic antigen (CEA), and CYFRA21-1.
    Type: Application
    Filed: April 11, 2019
    Publication date: May 20, 2021
    Applicant: Board of Regents, The University of Texas System
    Inventors: Robert BRESALIER, Nachman MAZUREK, James C. BYRD
  • Patent number: 10620206
    Abstract: Methods for detecting colorectal cancer in a subject by detection of a galactose-containing 40 kDa molecule in a serum sample from the subject. Methods for quantifying the amount of a galactose-containing molecule in a serum sample are also provided.
    Type: Grant
    Filed: October 5, 2017
    Date of Patent: April 14, 2020
    Assignee: Board of Regents, The University of Texas System
    Inventors: Robert Bresalier, Nachman Mazurek, James C. Byrd
  • Publication number: 20180031560
    Abstract: Methods for detecting colorectal cancer in a subject by detection of a galactose-containing 40 kDa molecule in a serum sample from the subject. Methods for quantifying the amount of a galactose-containing molecule in a serum sample are also provided.
    Type: Application
    Filed: October 5, 2017
    Publication date: February 1, 2018
    Applicant: Board of Regents, The University of Texas System
    Inventors: Robert BRESALIER, Nachman MAZUREK, James C. BYRD
  • Patent number: 9810691
    Abstract: Methods for detecting colorectal cancer in a subject by detection of a galactose-containing 40 kDa molecule in a serum sample from the subject. Methods for quantifying the amount of a galactose-containing molecule in a serum sample are also provided.
    Type: Grant
    Filed: October 10, 2012
    Date of Patent: November 7, 2017
    Assignee: Board of Regents, The University of Texas System
    Inventors: Robert Bresalier, Nachman Mazurek, James C. Byrd
  • Publication number: 20140378558
    Abstract: Methods for detecting colorectal cancer in a subject by detection of a galactose-containing 40 kDa molecule in a serum sample from the subject. Methods for quantifying the amount of a galactose-containing molecule in a serum sample are also provided.
    Type: Application
    Filed: October 10, 2012
    Publication date: December 25, 2014
    Applicant: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Robert Bresalier, Nachman Mazurek, James C. Byrd
  • Publication number: 20070250753
    Abstract: In a multiple access environment, to improve decoding efficiency for small code blocks by a constituent decoder, multiple code blocks may be concatenated to form a single larger code block. Example embodiments of the present invention concatenate code blocks for turbo codes I and II. Example embodiments of the present invention may also concatenate code blocks for convolutional code. Example embodiments of the present invention also disclose a system to concatenate the code blocks.
    Type: Application
    Filed: April 6, 2006
    Publication date: October 25, 2007
    Inventors: Robert Bresalier, Francis Dominique, Emad Farag, Hongwei Kong